99 related articles for article (PubMed ID: 7927470)
1. [Systemic B-cell response in the mouse after mucosal immunization with measles virus].
Muller CP; Brons NH
Immun Infekt; 1994 Jun; 22(3):125-6. PubMed ID: 7927470
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
[TBL] [Abstract][Full Text] [Related]
3. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
Chabot S; Brewer A; Lowell G; Plante M; Cyr S; Burt DS; Ward BJ
Vaccine; 2005 Feb; 23(11):1374-83. PubMed ID: 15661386
[TBL] [Abstract][Full Text] [Related]
4. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
Aleksandrowicz J; Polna I; Sadowski W
Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
[No Abstract] [Full Text] [Related]
5. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adenovirus-vectored vaccine for measles.
Lobanova LM; Baig TT; Tikoo SK; Zakhartchouk AN
Vaccine; 2010 Nov; 28(48):7613-9. PubMed ID: 20887832
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
[TBL] [Abstract][Full Text] [Related]
9. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
10. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
[TBL] [Abstract][Full Text] [Related]
11. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
Liashenko VA; Krasnova VP; Youminova NV
Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
Valosky J; Hishiki H; Zaoutis TE; Coffin SE
Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
[TBL] [Abstract][Full Text] [Related]
15. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice.
de Haan A; Tomee JF; Huchshorn JP; Wilschut J
Vaccine; 1995 Oct; 13(14):1320-4. PubMed ID: 8585287
[TBL] [Abstract][Full Text] [Related]
16. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
[TBL] [Abstract][Full Text] [Related]
17. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
[TBL] [Abstract][Full Text] [Related]
18. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
Yao XY; Yuan MM; Li DJ
Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
[TBL] [Abstract][Full Text] [Related]
19. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of UV-inactivated measles virus.
Zahorska R; Mazur N; Korbecki M
Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):424-30. PubMed ID: 696055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
